---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-022711"
form_type: "8-K"
ticker: "INAB"
cik: "0001740279"
company_name: "IN8BIO, INC."
filed_at: "2025-02-07T23:59:59+00:00"
generated_at: "2026-05-27T00:59:35.019553+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# IN8bio receives Nasdaq bid-price extension to Aug 4, 2025; stock moves to Capital Market

## Summary
- Nasdaq granted IN8bio until Aug 4, 2025 to achieve $1.00 closing bid for 10 consecutive days.
- Common stock transferred from Nasdaq Global Market to Nasdaq Capital Market effective Feb 7, 2025.
- Company may consider reverse stock split to regain compliance if needed.
- 2025 Annual Meeting set for May 8; record date March 12, 2025.
- Stockholder proposals and director nominations due Feb 17, 2025; universal proxy notice due March 9.

## SEC filing metadata
- accession: 0001193125-25-022711
- form_type: 8-K
- ticker: INAB
- cik: 0001740279
- company_name: IN8BIO, INC.
- filed_at: 2025-02-07T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 5.08
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1740279/000119312525022711/0001193125-25-022711-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1740279/000119312525022711/d841361d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-022711
- JSON: https://secwatch.observer/filing/0001193125-25-022711.json
- Plain text: https://secwatch.observer/filing/0001193125-25-022711.txt

## Source-grounded claims
- claim_id: 28d6ff06b1e5a3dde94b59080e13807034870061
  claim: IN8BIO, INC. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).
  evidence_excerpt: February 5, 2025, IN8bio, Inc. (the “Company”) received a notice (the “Extension Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) informing the Company that Nasdaq granted the Com
  evidence_url: https://www.sec.gov/Archives/edgar/data/1740279/000119312525022711/0001193125-25-022711-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.